UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OR The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported)            January 14, 2005   
                                                 -------------------------------

                              Invacare Corporation
             (Exact name of registrant as specified in its charter)

Ohio                                  0-12938              95-2680965  
--------------------------------------------------------------------------------
(State or other jurisdiction of     (Commission    (IRS Employer Identification)
incorporation or organization)     File Number No)

            One Invacare Way, P.O. Box 4028, Elyria, Ohio              44036    
--------------------------------------------------------------------------------
             (Address of principal executive offices)                (Zip Code)


Registrant's telephone number, including area code        (440) 329-6000        
                                                  ------------------------------

________________________________________________________________________________
                                                                   
(Former name, former address and former fiscal year, if change since last 
 report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))



Item 1.01  Entry into a Material Definitive Agreement.

The  information  set  forth  below in Item  2.03 of this  report of Form 8-K is
incorporated herein be reference.
                                                                               
Item 2.03  Creation of a Direct Financial  Obligation or an Obligation under an
           Off-Balance Sheet Arrangement of a Registrant.

On January 14, 2005,  Invacare  Corporation  ("Invacare")  entered into a Credit
Agreement (the "Agreement") with Certain Borrowing Subsidiaries, the Banks Named
Therein, and JPMorgan Chase Bank, N.A. as Agent, Keybank National Association as
Syndication  Agent,  and J.P.  Morgan  Securities,  Inc.  and  Keybank  National
Association,  as Co-Lead Arrangers.  The new $450 million  multi-currency credit
facility  available  to Invacare  under the  Agreement  replaces  the  Company's
previous $325 million  facility and  refinances the bridge loan in place to fund
the purchase of WP Domus GmbH in September 2004. The new facility  provides that
Invacare may, upon consent of its lenders,  increase the amount of the facility
by an additional $100 million to $550 million. All borrowings under the facility
are required to be repaid by January 14, 2010.

The borrowing rate under the Agreement is determined  based on the ratio of debt
to earnings before interest,  taxes,  depreciation and amortization  (EBITDA) of
Invacare,  as defined  in the  Agreement,  and  ranges  from LIBOR plus 0.35% to
0.675%.  In addition,  the Agreement  contains certain  affirmative and negative
covenants with respect to, among other things, interest coverage, net worth, and
ratio of debt to EBITDA.  The  Agreement  specifies  various  events of default,
including, among others, the failure to make payments when due and noncompliance
with  covenants.  Upon the  occurrence  of an event of default,  the lenders can
declare all amounts outstanding under the facility due and payable.

Also on January 14, 2005, Invacare's prior $325 million credit facility and $100
million  bridge  financing  were  terminated  as they  were  paid  in full  with
borrowings  under the new facility.  Invacare drew down $379.4 million under the
new  credit  facility  to repay  amounts  outstanding  under  the  prior  credit
facilities.

The  Agreement is filed as Exhibit 10.1 to this report on Form 8-K.

Item 7.01   Regulation FD Disclosure.

On January 19, 2005, the Company  issued a press release  announcing the signing
of the  Agreement.  The press release is attached as Exhibit 99.1 to this report
on Form 8-K.

Item 9.01   Financial Statements and Exhibits.
        
 (c)   Exhibits
 
     Exhibit  10.1  Credit   Agreement   dated  as  of  January  14,  2005 among
                    Invacare Corporation and Certain Borrowing Subsidiaries, the
                    Banks Named Therein, and JPMorgan Chase Bank, N.A. as Agent,
                    Keybank  National  Association  as Syndication  Agent,  J.P.
                    Morgan Securities, Inc. and Keybank National Association, as
                    Co-Lead Arrangers.

     Exhibit 99.1   Invacare press release dated January 19, 2005.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.




                               INVACARE CORPORATION


                           By:/s/ Gregory C. Thompson                  
                              -----------------------------------------
                              Gregory C. Thompson
                              Senior Vice President and Chief Financial Officer
                             (Principal Financial and Accounting Officer)



Date:  January 19, 2005